We report the isolation of a heretofore unrecognized brain Upid that is present in cerebrospinal fluid of sleep-deprived cats. The molecule appears to be a long-chain base structurally related to sphingosine and sph nane in which a second unsaturated bond has been introduced. An increase in the degree of unsaturation of a key membrane component is expected to have important physiological consequences. (Liberty Laboratories, Liberty Corner, NJ) were used for these studies. Subjects weighed 3.0-4.2 kg at the time of sampling. In order to establish a chronic cerebroventricular cannula, subjects were first placed under general anesthesia (halothane), intubated, and restrained in a feline stereotaxic apparatus (Kopf Instruments, Tujunga, CA). A trephine hole was then drilled in the cranial vault through which a stainless steel cannula (Plastic Products, Roanoke, VA) was inserted, directed toward either the fourth (two cats) or the right lateral (two cats) ventricle. Patency of the cannula placement was confirmed by observing spontaneous flow of clear CSF from the external tip of the cannula or by the ability to draw CSF from the cannula with a microliter syringe (Hamilton). The cannula and a fixed internal stilette were then encased and secured to the cranium by dental acrylic cement. Subjects were allowed at least 2 weeks of recovery prior to sampling of biological fluids. Subjects were group housed in a vivarium with regulated temperature and a 12-hr light/dark cycle (lights on at 6:30 a.m.; lights off at 6:30 p.m.). CSF samples were extracted between 10:00 a.m. and 12:30 a.m. The CSF sampling procedure involved removal of the internal stilette and insertion of a small diameter cannula that extended one millimeter beyond the tip ofthe implanted cannula. CSF was then drawn into a 100-A4 Hamilton syringe and immediately placed into a small plastic container (Eppendorf microcentrifuge tube) and placed into a bucket filled with dry ice. Samples were then transferred to a -700C freezer until analytical analysis. A total of six samples were collected in this fashion. Individual samples varied in volume from 150 to 300 /4. In addition to this procedure, two cats were placed on an enclosed, slow-moving treadmill for 22 hr. thereby enforcing partial sleep deprivation. One CSF sample of these subjects was taken following this period of sleep deprivation. Finally, two additional CSF samples were taken from ketamineanesthetized cats by acute transcutaneous puncture through the cisterna magna.
The concept that there is an endogenous sleep substance has a long and complicated history during which a large variety of substances have been proposed. Rather than investing in the pursuit of a particular physiological pathway or its attendant receptor-ligand system, we have taken a purely chemical approach to the problem by attempting to identify directly molecules of the central nervous system which vary during the sleep-wake cycle. The driving force for these experiments is the realization that the sensitivity of modem analytical techniques should allow for a fresh look at timehonored problems such as the chemical basis of sleep. Using such techniques, we have identified a unique molecule in the cerebrospinal fluid (CSF) of sleep-deprived cats. We will refer to the molecule as cerebrodiene in recognition of its source and the likely presence of a diene. Given the central role of sphingoid bases in the brain (1, 2) , this molecule can be expected to play an important role in physiological processes.
METHODS
Sleep Deprivation and Collection of Feline CSF. Four adult female specific-pathogen-free cats (Liberty Laboratories, Liberty Corner, NJ) were used for these studies. Subjects weighed 3.0-4.2 kg at the time of sampling. In order to establish a chronic cerebroventricular cannula, subjects were first placed under general anesthesia (halothane), intubated, and restrained in a feline stereotaxic apparatus (Kopf Instruments, Tujunga, CA). A trephine hole was then drilled in the cranial vault through which a stainless steel cannula (Plastic Products, Roanoke, VA) was inserted, directed toward either the fourth (two cats) or the right lateral (two cats) ventricle. Patency of the cannula placement was confirmed by observing spontaneous flow of clear CSF from the external tip of the cannula or by the ability to draw CSF from the cannula with a microliter syringe (Hamilton). The cannula and a fixed internal stilette were then encased and secured to the cranium by dental acrylic cement. Subjects were allowed at least 2 weeks of recovery prior to sampling of biological fluids. Subjects were group housed in a vivarium with regulated temperature and a 12-hr light/dark cycle (lights on at 6:30 a.m.; lights off at 6:30 p.m.). CSF samples were extracted between 10:00 a.m. and 12:30 a.m. The CSF sampling procedure involved removal of the internal stilette and insertion of a small diameter cannula that extended one millimeter beyond the tip ofthe implanted cannula. CSF was then drawn into a 100-A4 Hamilton syringe and immediately placed into a small plastic container (Eppendorf microcentrifuge tube) and placed into a bucket filled with dry ice. Samples were then transferred to a -700C freezer until analytical analysis. A total of six samples were collected in this fashion. Individual samples varied in volume from 150 to 300 /4. In addition to this procedure, two cats were placed on an enclosed, slow-moving treadmill for 22 hr. thereby enforcing partial sleep deprivation. One CSF sample of these subjects was taken following this period of sleep deprivation. Finally, two additional CSF samples were taken from ketamineanesthetized cats by acute transcutaneous puncture through the cisterna magna.
HPLC Experiments. Preparative HPLC analysis of CSF was performed on a Pharmacia LKB Biotechnology SMART system with a MicroPeak monitor. A pRPC C2/C18, SC 2/10 column was used to perform the separation; a flow of 100 /4/min was maintained with a 1% acetonitrile/water (0.1% trifluoroacetic acid) gradient. The fraction collector collected the sample directly from the detector, which monitored absorbance at two wavelengths, 215 and 280 nm. Direct coupling between the mass spectrometer and a Michrom HPLC was also achieved.
Mass Spectrometry. The MS experiments were performed on an API III Perkin-Elmer SCIEX triple-quadrupole mass spectrometer and a Fisons/VG ZAB-VSE high-resolution magnetic-sector mass spectrometer. The pneumatically assisted electrospray interface on the SCIEX was used for sample introduction with the potential of the interface sprayer maintained at 5.0 kV. A curtain gas of ultrapure nitrogen (1.0 liter/min) between the interface plate and the sampling orifice was applied to aid desolvation ofthe charged droplets and to prevent particulate matter from entering the analyzer region. Samples were introduced through the interface at a rate of 4.0 A4/min. The positive ions generated by the ion evaporation process entered the analyzer through an interface plate and a 100-jum orifice. The declustering potential was maintained between 50 and 250 V (typically 100 V) to control the collisional energy of the entering ions. A cryogenic pump was used to cool the surfaces within the spectrometer (14-18 K), maintaining a working pressure of 2 X 10-5 torr (1 torr = 133 Pa) and a sealed pressure of 8 x 10-8 torr in the analyzer region. The Fisons/VG ZAB-VSE instrument was used to perform the exact mass determination on the unknown compound by fast-atom bombardment analysis; a resolution of 10,000 (10%o valley definition) was obtained to perform an exact mass measurement to within 0.7 parts per million.
Collision-Induced Dissociation (CID). The CID experiments were performed on the API III Perkin-Elmer SCIEX triplequadrupole mass spectrometer with ultrapure argon (>99.99%o purity) as a collision gas. The positive-ion MS/MS Abbreviations: CSF, cerebrospinal fluid; CID, collision-induced dissociation; MS2, MS/MS; MS3, MS/MS/MS. tTo whom reprint requests should be addressed.
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Proc. Natl. Acad. Sci. USA 91 (1994) (MS2) data were acquired by mass selecting the precursor ion with the first quadrupole; collisions with argon (target thickness of 3 x 1014 atoms/cm2) in the second quadrupole produced dissociation. The third quadrupole analyzed the mass of the resultant daughter ions. Collision energies of 80 eV were maintained in these experiments. CID spectra shown were the result of averaging 50-100 scans, depending on the number of scans necessary to obtain a signal-to-noise ratio 2 50. MS/MS/MS (MS3) data were also obtained by mass selecting a daughter ion generated at the orifice with the first quadrupole mass analyzer. Collisions with argon (target thickness of 3 x 1014 atoms/cm2) in the second quadrupole collision cell produced further dissociation and the resultant granddaughter ions were analyzed with the third quadrupole mass analyzer. RESULTS HPLC analysis of feline CSF produced a peak which was often present in sleep-deprived but not normal cats. Even though this compound was present in only small amounts (0.1-5 pmol/100 p4), its tentative identity could be determined by modem MS methods. The data were derived from 200 p1 of CSF.
Initial electrospray mass analysis of this HPLC peak revealed mass peaks of m/z 282, 304, 320, and 564 (Fig. 1) . Fig. 4 . From these preliminary studies, the candidate structures 1-6 are now known not to be identical to cerebrodiene, and 7-9, while similar, exhibit MS characteristics that make them unlikely to represent the structure of the natural agent. On the other hand, the candidate structures 10-12 exhibited characteristics (MS fragmentation and relative intensities, UV, and NMR) nearly identical to those of cerebrodiene. Although the unavailability of sufficient authentic cerebrodiene presently precludes a correlation with the candidate structures 10-12, their similarities to the subtle distinguishing characteristics of cerebrodiene strongly suggest that the second olefin is remote from the firmly established A3'4-olefin. 
DISCUSSION

